- Student Records
Programme & Unit Catalogues


PA50233: Infections

Follow this link for further information on academic years Academic Year: 2018/9
Further information on owning departmentsOwning Department/School: Department of Pharmacy & Pharmacology
Further information on credits Credits: 6      [equivalent to 12 CATS credits]
Further information on notional study hours Notional Study Hours: 120
Further information on unit levels Level: Masters UG & PG (FHEQ level 7)
Further information on teaching periods Period:
Modular (no specific semester)
Further information on unit assessment Assessment Summary: CW 100%
Further information on unit assessment Assessment Detail:
  • Assessment Group A: Medicines Optimisation Tool (ass't grp A) (CW 40%)
  • Assessment Group A: Case Based Discussion (ass't grp A) (CW 20%)
  • Assessment Group A: CARE Tool (ass't grp A) (CW 10%)
  • Assessment Group A: Service Evaluation (ass't grp A) (CW 30%)
  • Assessment Group B: Medicines Optimisation Tool (ass't grp B) (CW 40%)
  • Assessment Group B: Case Based Discussion (ass't grp B) (CW 20%)
  • Assessment Group B: CARE Tool (ass't grp B) (CW 10%)
  • Assessment Group B: Guideline Review (ass't grp B) (CW 30%)
  • Assessment Group C: Medicines Optimisation Tool (ass't grp C) (CW 40%)
  • Assessment Group C: Case Based Discussion (ass't grp C) (CW 20%)
  • Assessment Group C: CARE Tool (ass't grp C) (CW 10%)
  • Assessment Group C: Teaching Session (ass't grp C) (CW 30%)
  • Assessment Group D: Medicines Optimisation Tool (ass't grp D) (CW 40%)
  • Assessment Group D: Case Based Discussion (ass't grp D) (CW 20%)
  • Assessment Group D: CARE Tool (ass't grp D) (CW 10%)
  • Assessment Group D: Designated Alternative ASP (ass't grp D) (CW 30%)
Further information on supplementary assessment Supplementary Assessment:
Like-for-like reassessment (where allowed by programme regulations)
Further information on requisites Requisites:
Further information on descriptions Description: Aims:
To update pharmacists on infectious diseases and patient monitoring factors that should be considered when providing pharmaceutical care for these patients.

Learning Outcomes:
On successful completion of this unit the student will be able to:
1. Describe and analyse the role of the healthcare professional/ pharmacist in prescribing and monitoring medication for patients with infectious diseases (knowledge and understanding).
2. Explain the disease and patient monitoring factors that are influenced in this therapeutic area (knowledge and understanding, professional practical skill).
3. Critically evaluate the evidence base and medicines management issues for treatment of infectious diseases and be able to present this information to your peer group (intellectual skill).
4. Reflect on their own practice in prescribing and medicines management issues for these patients and identify areas for continuous improvement (personal transferable skill).
5. Apply the knowledge gained in this unit to design enhancements to patient facing services and the patient experience (professional practical skill; intellectual skill; knowledge and understanding).

Skills:

* Planning & organisation (Taught/Facilitated)
* Handling information (Taught)
* Written communication (Taught/Facilitated/Assessed)
* Working with others (Taught)
* Improving learning & performance (Taught/Facilitated/Assessed)
* Information & communication technology (ICT) (Taught/Facilitated)
* Problem solving (Taught/Facilitated/Assessed).

Content:

* Infections & The NHS
* Causes & Clinical Manifestations of Infections
* Antimicrobial Chemotherapy
* Management of Infections
- Central nervous system
- Eye
- Ear
- Cardiovascular
- Respiratory
- Gastrointestinal
- Urinary tract
- Sexually transmitted
- Skin
- Septicaemia
- HIV
* Pharmacoeconomics.
Further information on programme availabilityProgramme availability:

PA50233 is Optional on the following programmes:

Department of Pharmacy & Pharmacology

Notes: